Literature DB >> 12699838

Transcoronary sinus delivery of autologous bone marrow and angiogenesis in pig models with myocardial injury.

J Vicario1, J Piva, A Pierini, H H Ortega, A Canal, L Gerardo, H Pfeiffer, C Campos, I Fendrich, R Novero, A Monti.   

Abstract

PURPOSE: The aim of the investigation is to study myocardial injury on pig model with two objectives: (1) feasibility of stimulating angiogenesis with fresh autologous bone marrow; (2) administration of the same fresh autologous bone marrow via coronary sinus with transitory occlusion.
METHODS: A controlled study was done in animal model with three phases, in a study group of 12 pigs (bone marrow administration) as well as in control group of 4 pigs (saline administration). Phase 1-production of coronary stenosis and myocardial injury; Phase 2-two weeks later, administration of bone marrow through coronary sinus with 10 min occlusion in the study group and saline solution in the control group. Phase 3-two weeks later, histological staining with hematoxylin-eosin and inmunohistochemical staining with monoclonal antibody for smooth muscle alpha-actin were conducted on both study and control groups.
RESULTS: The percentage of angionenesis observed in the study group was 91% and 0% in control group. Counting of positive actin in affected and control areas showed statistically significant differences in relation to both groups: study group (1.37 vs. 0.79) and control group (0.47 vs. 0.51). The percentage of mononuclear immature cells observed in the myocardium in the study group was 25% and in the control group was 0%. There was no increment in the coronary collateral circulation when comparing coronary angiography.
CONCLUSIONS: Autologous bone marrow in animal model with experimental myocardial injury enhances angiogenesis, as well as vessels with smooth muscles. The transitory occlusion of the coronary sinus might be an effective way to administer cells as those from the bone marrow.

Entities:  

Mesh:

Year:  2002        PMID: 12699838     DOI: 10.1016/s1522-1865(03)00002-7

Source DB:  PubMed          Journal:  Cardiovasc Radiat Med        ISSN: 1522-1865


  10 in total

Review 1.  Human coronary venous anatomy: implications for interventions.

Authors:  Julianne H Spencer; Sara E Anderson; Paul A Iaizzo
Journal:  J Cardiovasc Transl Res       Date:  2013-01-11       Impact factor: 4.132

Review 2.  Neovascularization derived from cell transplantation in ischemic myocardium.

Authors:  Denis Angoulvant; Shafie Fazel; Ren-Ke Li
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 3.  Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium.

Authors:  Tycho I G van der Spoel; Joe Chun-Tsu Lee; Krijn Vrijsen; Joost P G Sluijter; Maarten Jan M Cramer; Pieter A Doevendans; Eric van Belle; Steven A J Chamuleau
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-25       Impact factor: 2.357

4.  New coronary retroinfusion technique in the Rat infarct model: transjugular cardiac vein catheterization.

Authors:  Zheyong Huang; Yunli Shen; Hongmin Zhu; Jianfeng Xu; Yanan Song; Xinying Hu; Zhang Shuning; Xiangdong Yang; Aijun Sun; Juying Qian; Junbo Ge
Journal:  Exp Anim       Date:  2013

5.  Therapeutic payload delivery to the myocardium: Evolving strategies and obstacles.

Authors:  Tarek Shazly; Arianna Smith; Mark J Uline; Francis G Spinale
Journal:  JTCVS Open       Date:  2022-05-05

Review 6.  Current stem cell delivery methods for myocardial repair.

Authors:  Calvin C Sheng; Li Zhou; Jijun Hao
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

Review 7.  Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy.

Authors:  Han Shen; Ying Wang; Zhiwei Zhang; Junjie Yang; Shijun Hu; Zhenya Shen
Journal:  Stem Cells Int       Date:  2015-08-03       Impact factor: 5.443

8.  Progenitor Hematopoietic Cells Implantation Improves Functional Capacity of End Stage Coronary Artery Disease Patients with Advanced Heart Failure.

Authors:  Yoga Yuniadi; Yuyus Kusnadi; Lakshmi Sandhow; Rendra Erika; Dicky A Hanafy; Caroline Sardjono; R W M Kaligis; Manoefris Kasim; Ganesja M Harimurti
Journal:  Cardiol Res Pract       Date:  2016-04-11       Impact factor: 1.866

Review 9.  Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data.

Authors:  Wouter A Gathier; Dirk Jan van Ginkel; Mira van der Naald; Frebus J van Slochteren; Pieter A Doevendans; Steven A J Chamuleau
Journal:  J Cardiovasc Transl Res       Date:  2018-02-01       Impact factor: 4.132

10.  Lower retention after retrograde coronary venous infusion compared with intracoronary infusion of mesenchymal stromal cells in the infarcted porcine myocardium.

Authors:  Wouter A Gathier; Mira van der Naald; Bas R van Klarenbosch; Anton E Tuinenburg; John Lm Bemelmans; Klaus Neef; Joost Pg Sluijter; Frebus J van Slochteren; Pieter A Doevendans; Steven Aj Chamuleau
Journal:  BMJ Open Sci       Date:  2019-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.